Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Thomas

Showing results (111-120 of 218) with videos related to

Pageof 22
Sort By:
The European Respiratory Journal|July 25, 2015
Mefloquine as a potential drug against multidrug-resistant tuberculosisDavid Krieger, Silvan Vesenbeckh, Nicolas Schönfeld, et al.
Environmental Microbiome|April 27, 2021
Tax4Fun2: prediction of habitat-specific functional profiles and functional redundancy based on 16S rRNA gene sequencesFranziska Wemheuer, Jessica A Taylor, Rolf Daniel, et al.
International Journal of Molecular Sciences|January 8, 2020
Physiological and Metabolic Effects of Yellow Mangosteen (<i>Garcinia dulcis</i>) Rind in Rats with Diet-Induced Metabolic SyndromeOliver D John, Peter Mouatt, Marwan E Majzoub, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2012
Functional equivalence and evolutionary convergence in complex communities of microbial sponge symbiontsLu Fan, David Reynolds, Michael Liu, et al.
The European Respiratory Journal|March 24, 2017
Bedaquiline as a potential agent in the treatment of <i>M. intracellulare</i> and <i>M. avium</i> infectionsSilvan Vesenbeckh, Nicolas Schönfeld, David Krieger, et al.
Tuberculosis (Edinburgh, Scotland)|May 10, 2016
Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosisSilvan Vesenbeckh, David Krieger, Gudrun Bettermann, et al.
The European Respiratory Journal|November 13, 2016
Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare?David Krieger, Nicolas Schönfeld, Silvan Vesenbeckh, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Coffee Pulp, a By-Product of Coffee Production, Modulates Gut Microbiota and Improves Metabolic Syndrome in High-Carbohydrate, High-Fat Diet-Fed RatsNikhil S Bhandarkar, Peter Mouatt, Marwan E Majzoub, et al.
Microbiome|June 23, 2019
Microbial indicators of environmental perturbations in coral reef ecosystemsBettina Glasl, David G Bourne, Pedro R Frade, et al.
Iscience|January 1, 2024
<i>In situ</i> devices can culture the microbial dark matter of coralsFlúvio Modolon, Júnia Schultz, Gustavo Duarte, et al.
Pageof 22

Showing results (111-120 of 218) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|July 25, 2015
Mefloquine as a potential drug against multidrug-resistant tuberculosisDavid Krieger, Silvan Vesenbeckh, Nicolas Schönfeld, et al.
Environmental Microbiome|April 27, 2021
Tax4Fun2: prediction of habitat-specific functional profiles and functional redundancy based on 16S rRNA gene sequencesFranziska Wemheuer, Jessica A Taylor, Rolf Daniel, et al.
International Journal of Molecular Sciences|January 8, 2020
Physiological and Metabolic Effects of Yellow Mangosteen (<i>Garcinia dulcis</i>) Rind in Rats with Diet-Induced Metabolic SyndromeOliver D John, Peter Mouatt, Marwan E Majzoub, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2012
Functional equivalence and evolutionary convergence in complex communities of microbial sponge symbiontsLu Fan, David Reynolds, Michael Liu, et al.
The European Respiratory Journal|March 24, 2017
Bedaquiline as a potential agent in the treatment of <i>M. intracellulare</i> and <i>M. avium</i> infectionsSilvan Vesenbeckh, Nicolas Schönfeld, David Krieger, et al.
Tuberculosis (Edinburgh, Scotland)|May 10, 2016
Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosisSilvan Vesenbeckh, David Krieger, Gudrun Bettermann, et al.
The European Respiratory Journal|November 13, 2016
Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare?David Krieger, Nicolas Schönfeld, Silvan Vesenbeckh, et al.
Pathogens (Basel, Switzerland)|November 27, 2021
Coffee Pulp, a By-Product of Coffee Production, Modulates Gut Microbiota and Improves Metabolic Syndrome in High-Carbohydrate, High-Fat Diet-Fed RatsNikhil S Bhandarkar, Peter Mouatt, Marwan E Majzoub, et al.
Microbiome|June 23, 2019
Microbial indicators of environmental perturbations in coral reef ecosystemsBettina Glasl, David G Bourne, Pedro R Frade, et al.
Iscience|January 1, 2024
<i>In situ</i> devices can culture the microbial dark matter of coralsFlúvio Modolon, Júnia Schultz, Gustavo Duarte, et al.
Pageof 22